- Home
- PATH vs CRNX Comparison
PATH vs CRNX Comparison
Compare PATH & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PATH
- CRNX
- Stock Information
- Founded
- PATH 2005
- CRNX 2008
- Country
- PATH United States
- CRNX United States
- Employees
- PATH N/A
- CRNX N/A
- Industry
- PATH Computer Software: Prepackaged Software
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- PATH Technology
- CRNX Health Care
- Exchange
- PATH Nasdaq
- CRNX Nasdaq
- Market Cap
- PATH 5.9B
- CRNX 5.2B
- IPO Year
- PATH 2021
- CRNX 2018
- Fundamental
- Price
- PATH $10.50
- CRNX $30.62
- Analyst Decision
- PATH Hold
- CRNX Strong Buy
- Analyst Count
- PATH 20
- CRNX 12
- Target Price
- PATH $12.97
- CRNX $73.36
- AVG Volume (30 Days)
- PATH 14.4M
- CRNX 1.1M
- Earning Date
- PATH 03-12-2025
- CRNX 05-08-2025
- Dividend Yield
- PATH N/A
- CRNX N/A
- EPS Growth
- PATH N/A
- CRNX N/A
- EPS
- PATH N/A
- CRNX N/A
- Revenue
- PATH $1,429,664,000.00
- CRNX $1,039,000.00
- Revenue This Year
- PATH $13.10
- CRNX $356.40
- Revenue Next Year
- PATH $10.51
- CRNX $845.76
- P/E Ratio
- PATH N/A
- CRNX N/A
- Revenue Growth
- PATH 9.30
- CRNX N/A
- 52 Week Low
- PATH $9.50
- CRNX $29.18
- 52 Week High
- PATH $22.11
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- PATH 36.81
- CRNX 31.91
- Support Level
- PATH $10.13
- CRNX $32.90
- Resistance Level
- PATH $11.41
- CRNX $35.26
- Average True Range (ATR)
- PATH 0.43
- CRNX 1.73
- MACD
- PATH 0.03
- CRNX -0.10
- Stochastic Oscillator
- PATH 52.36
- CRNX 19.86
About PATH UiPath Inc.
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.